Table 11.

Clinicopathological parameters of patients according to PD-L1 expression in the tumor.

Features	Number of Patients	PD-L1 Tumor-Negative	PD-L1 Tumor-Positive	p Value
	N = 24 (100%)	N = 18 (75%)	N = 6 (25%)
Gender
Male	14 (58%)	12 (67%)	2 (33%)	0.15
Female	10 (42%)	6 (33%)	4 (67%)
lymph nodes involvement
yes	14 (58%)	10 (56%)	4 (67%)	0.63
no	10 (42%)	8 (44%)	2 (33%)
distant metastases
yes	6 (25%)	5 (28%)	1 (17%)	0.58
no	18 (75%)	13 (72%)	5 (83%)
pSTAGE
I/II	10 (42%)	8 (44%)	2 (33%)	0.63
III/IV	14 (58%)	10 (56%)	4 (67%)
budding
Grade 1	15 (65%)	10 (59%)	5 (83%)	0.26
Grade 2/3	8 (35%)	7 (41%)	1 (17%)
TILS
TILS > 5%	15 (65%)	11 (65%)	4 (67%)	0.93
TILs ≤ 5%	8 (35%)	6 (35%)	2 (33%)